Rejuve.AI is projected to decline to $0.0003376 by 2027, a -52% move from its current price of $0.0007023. RJV is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 22/100 (Extreme Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 5/26/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.0006768 | $0.0007026 | $0.0007294 | +0.05% |
| May 30 | $0.0006667 | $0.0007029 | $0.0007411 | +0.09% |
| May 31 | $0.0006591 | $0.0007032 | $0.0007503 | +0.14% |
| Jun 1 | $0.0006528 | $0.0007035 | $0.0007582 | +0.18% |
| Jun 2 | $0.0006474 | $0.0007039 | $0.0007652 | +0.23% |
| Jun 3 | $0.0006425 | $0.0007042 | $0.0007717 | +0.27% |
| Jun 4 | $0.0006381 | $0.0007045 | $0.0007777 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0006381 | $0.0007045 | $0.0007777 | +0.32% |
| Week 2 | $0.0006145 | $0.0007067 | $0.0008128 | +0.63% |
| Week 3 | $0.0005973 | $0.000709 | $0.0008415 | +0.95% |
| Week 4 | $0.0005835 | $0.0007112 | $0.0008668 | +1.27% |
| Week 5 | $0.0005719 | $0.0007135 | $0.0008901 | +1.59% |
| Week 6 | $0.0005617 | $0.0007157 | $0.000912 | +1.91% |
| Week 7 | $0.0005526 | $0.000718 | $0.0009328 | +2.24% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Rejuve.AI is a decentralized, AI-driven longevity research network allowing people from all over the world to track their health data, receive valuable insights, contribute to cutting-edge longevity research, and earn rewards.
The asset is labeled Rejuve.AI (RJV) and sits within the BNB Chain Ecosystem, Cardano Ecosystem, Ethereum Ecosystem, and Decentralized Science (DeSci) categories.
This description portrays a worldwide, data-driven platform that blends health-tracking, research participation, and rewards within a multi-chain ecosystem, focused on longevity science.
Rejuve.AI (RJV) is currently trading at $0.0007023. It ranks 4075 by market capitalization, with a market cap of $376.28K.
The asset has seen an all-time high of $0.1437 and an all-time low of $0.0006529, illustrating a wide historical range. The forecast paints a varied path ahead, with distinct yearly outlooks rather than a single, flat trajectory.
Forecasts show 2026 near the current price with an avg of $0.0007023 and 0% ROI, then a mix of bearish and bullish years through 2030 and beyond. Notably, 2040 and 2050 projects offer higher avg prices and double-digit or near-double-digit ROIs, such as 2040 avg $0.001435 (104.3% ROI) and 2050 avg $0.001373 (95.5% ROI), signaling potential long-run upside amid volatility.
A major floor 33.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.6% away) — a key level to hold.
The nearest ceiling, 46.8% above — a clean break opens room to run.
A major ceiling 115.9% above — clearing it would confirm fresh momentum.
Key RJV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RJV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0007019 | Buy | $0.0007055 | Sell |
| MA 10 | $0.0007028 | Sell | $0.0007178 | Sell |
| MA 20 | $0.0007638 | Sell | $0.0007655 | Sell |
| MA 50 | $0.0009248 | Sell | $0.0009179 | Sell |
| MA 100 | $0.001131 | Sell | $0.00118 | Sell |
| MA 200 | $0.001611 | Sell | $0.001815 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.13 | Neutral |
| Stoch RSI (14) | 83.88 | Sell |
| CCI (20) | -59.24 | Neutral |
| Williams %R (14) | -82.92 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -8.11 | Sell |
| Bollinger %B (20,2) | 0.34 | Neutral |
| Stochastic %K (14) | 17.08 | Buy |
| TRIX (15) | -1.26 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 40.90 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 0.00 | Sell |
| ADX (14) | 35.18 | Sell |
| ATR (14) | 0.00 | Info |
The 30-day technical picture is neutral overall, with RSI14 at 30.
The short- to mid-term moving averages place the price below the longer-term momentum: SMA50 at $0.0009248 and SMA200 at $0.001611.
Key near-term levels are a support at $0.0006912 and a resistance at $0.001031, with the latest 30-day price range spanning $0.0005722 to $0.0008619.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0006912 | $0.0007023 | $0.0007023 | 0% | Neutral | |
| $0.000258 | $0.0003376 | $0.0004733 | -52% | Bearish | |
| $0.0007227 | $0.0009831 | $0.001443 | +40% | Bullish | |
| $0.0006487 | $0.000912 | $0.001389 | +30% | Bullish | |
| $0.0004933 | $0.0007142 | $0.001121 | +2% | Neutral | |
| $0.0003104 | $0.0004618 | $0.0007446 | -34% | Bearish | |
| $0.0006012 | $0.0009176 | $0.001515 | +31% | Bullish | |
| $0.0008163 | $0.001276 | $0.002153 | +82% | Bullish | |
| $0.0004884 | $0.0007817 | $0.001345 | +11% | Neutral | |
| $0.0002851 | $0.0004666 | $0.0008175 | -34% | Bearish | |
| $0.0007901 | $0.001435 | $0.002712 | +104% | Bullish | |
| $0.0006251 | $0.001373 | $0.002893 | +95% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.0006912 | $0.0007023 | $0.0008043 | +0.00% |
| June 2026 | $0.0005531 | $0.0006555 | $0.0007996 | -6.66% |
| July 2026 | $0.0006105 | $0.0007318 | $0.0009087 | +11.64% |
| August 2026 | $0.0005654 | $0.0006839 | $0.000861 | -6.54% |
| September 2026 | $0.0004809 | $0.0005861 | $0.0007461 | -14.31% |
| October 2026 | $0.0004974 | $0.0006104 | $0.000785 | +4.16% |
| November 2026 | $0.0004996 | $0.0006168 | $0.0008003 | +1.05% |
| December 2026 | $0.0003912 | $0.0004859 | $0.0006357 | -21.22% |
Click any year to see its month-by-month RJV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect RJV to range from $0.0006912 to $0.0007023 through 2026. The $0.0007023 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The RJV price prediction for 2027 points to an average of $0.0003376 (low $0.000258, high $0.0004733) — a potential decline of -52% on today's $0.0007023. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2028, RJV is projected to trade between $0.0007227 and $0.001443, averaging $0.0009831 — a potential gain of +40% from today's $0.0007023. That is up +191% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Rejuve.AI's 2029 outlook centres on $0.000912, within a $0.0006487 to $0.001389 range. That is -7% versus the projected 2028 average. That marks a +30% change versus current levels. Momentum favours further upside here.
By 2030, RJV could reach as high as $0.001121, with a base case around $0.0007142 and support toward $0.0004933 — roughly +2% from $0.0007023. A consolidation phase looks the most probable path here.
Expect RJV to range from $0.0003104 to $0.0007446 through 2031. The $0.0004618 average target implies a -34% move from current prices. That is -35% versus the projected 2030 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The RJV price prediction for 2032 points to an average of $0.0009176 (low $0.0006012, high $0.001515) — a potential gain of +31% on today's $0.0007023. Buyers look set to stay in control over this stretch.
In 2033, RJV is projected to trade between $0.0008163 and $0.002153, averaging $0.001276 — a potential gain of +82% from today's $0.0007023. That is up +39% on the projected 2032 average. Momentum favours further upside here.
Rejuve.AI's 2034 outlook centres on $0.0007817, within a $0.0004884 to $0.001345 range. That is -39% versus the projected 2033 average. That marks a +11% change versus current levels. A consolidation phase looks the most probable path here.
By 2035, RJV could reach as high as $0.0008175, with a base case around $0.0004666 and support toward $0.0002851 — roughly -34% from $0.0007023. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect RJV to range from $0.0007901 to $0.002712 through 2040. The $0.001435 average target implies a +104% move from current prices. That is up +208% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The RJV price prediction for 2050 points to an average of $0.001373 (low $0.0006251, high $0.002893) — a potential gain of +95% on today's $0.0007023. Momentum favours further upside here.
Investing $1,000 in RJV today (≈ 1,423,953.749982 RJV) could be worth
$1,954.79
+$954.79 (+95%) by 2050 · US Dollar
Based on the average projected RJV price of $0 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RJVwould be worth at today's price.
$1,000 invested in RJV on May 27, 2025 (≈ 139,934.27525 RJV) would be worth
$98.27
-$901.73 (-90.2%) today · 0.10× · US Dollar
Based on a RJV entry price of $0.007146 vs. today's $0.000702.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.000707 | $993 | -0.7% |
| 1 month ago | $0.001091 | $643.92 | -35.6% |
| 3 months ago | $0.001265 | $555.02 | -44.5% |
| 6 months ago | $0.001292 | $543.52 | -45.6% |
| 1 year ago | $0.007146 | $98.27 | -90.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RJV forecast.
Our base-case forecast reaches $0.0014 around 2040.
Implied market cap at $0.0014: $750.16K
The multi-year forecast shows a varied path, with notable milestones in 2028 and in the 2040–2050 horizon. In 2028 the avg is $0.0009831 with a 40% ROI and a BULLISH sentiment, while 2030 sees an avg of $0.0007142 and a 1.7% ROI with NEUTRAL sentiment. The 2040 forecast jumps to an avg of $0.001435 and a 104.3% ROI, holding a BULLISH tone, and 2050 projects an avg of $0.001373 with a 95.5% ROI, also BULLISH.
Bearish years appear in 2027 (-51.9% ROI, BEARISH), 2031 (-34.2%), and 2035 (-33.6%). The forecast also highlights 2033 with a strong bullish signal: avg $0.001276 and ROI 81.8%, and 2032 with avg $0.0009176 and ROI 30.7%.
Overall, the long-run outlook suggests potential upside across several years but comes with substantial variability and risk, as reflected in the annualized volatility and the mix of bullish and bearish periods.
Tap a question to reveal the answer.
In 2030 the avg price is $0.0007142 and the min/max are $0.0004933/$0.001121, with a ROI of 1.7% and sentiment NEUTRAL.
Forecasts show a mix of outcomes: 2027 is bearish (-51.9% ROI), 2028 and 2029 turn bullish (40% and 29.9% ROIs), and 2040 and 2050 show strong bullish potential (104.3% and 95.5% ROIs). These are estimates, not guarantees, and signaling can shift with market conditions.
Yes. The forecast includes max values above $0.001 in several years: 2028 max $0.001443, 2029 max $0.001389, 2033 max $0.002153, 2040 max $0.002712, and 2050 max $0.002893.
Current price is $0.0007023. The market capitalization is $376.28K, and it is ranked 4075.
The long-term outlook shows potential upside in years like 2040 (avg $0.001435; ROI 104.3%, BULLISH) and 2050 (avg $0.001373; ROI 95.5%, BULLISH), with mid-term neutral and occasional bearish years such as 2027 (-51.9% ROI) and 2031 (-34.2%).
Rejuve.AI Community Discussion
0Share your Rejuve.AI price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.